Vaughan David Investments’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,793
Closed -$220K 238
2025
Q4
$220K Hold
2,793
﹤0.01% 220
2025
Q3
$230K Hold
2,793
0.01% 215
2025
Q2
$225K Sell
2,793
-600
-18% -$46.3K 0.01% 220
2025
Q1
$272K Hold
3,393
0.01% 189
2024
Q4
$278K Sell
3,393
-200
-6% -$16.6K 0.01% 188
2024
Q3
$296K Hold
3,593
0.01% 185
2024
Q2
$252K Hold
3,593
0.01% 191
2024
Q1
$266K Hold
3,593
0.01% 194
2023
Q4
$238K Sell
3,593
-74
-2% -$4.63K 0.01% 192
2023
Q3
$231K Buy
3,667
+76
+2% +$4.73K 0.01% 182
2023
Q2
$203K Buy
3,591
+1
+0% +$55 0.01% 199
2023
Q1
$208K Buy
3,590
+1
+0% +$67 0.01% 195
2022
Q4
$260K Sell
3,589
-800
-18% -$57.3K 0.01% 179
2022
Q3
$267K Sell
4,389
-157
-3% -$10K 0.01% 173
2022
Q2
$285K Sell
4,546
-527
-10% -$34.9K 0.01% 166
2022
Q1
$357K Sell
5,073
-2,700
-35% -$183K 0.01% 161
2021
Q4
$486K Sell
7,773
-12
-0.2% -$753 0.01% 151
2021
Q3
$481K Hold
7,785
0.02% 147
2021
Q2
$466K Sell
7,785
-650
-8% -$41.2K 0.01% 156
2021
Q1
$513K Sell
8,435
-1,840
-18% -$102K 0.02% 139
2020
Q4
$482K Sell
10,275
-2,500
-20% -$108K 0.02% 138
2020
Q3
$475K Sell
12,775
-1,300
-9% -$49.3K 0.02% 135
2020
Q2
$514K Sell
14,075
-960
-6% -$33.4K 0.02% 127
2020
Q1
$460K Sell
15,035
-1,904
-11% -$84.4K 0.02% 129
2019
Q4
$863K Sell
16,939
-2,350
-12% -$113K 0.03% 119
2019
Q3
$910K Sell
19,289
-3,420
-15% -$163K 0.03% 120
2019
Q2
$1.13M Sell
22,709
-3,964
-15% -$186K 0.04% 110
2019
Q1
$1.14M Sell
26,673
-373,868
-93% -$16.5M 0.05% 111
2018
Q4
$16.4M Buy
400,541
+6,791
+2% +$291K 0.77% 67
2018
Q3
$18.4M Sell
393,750
-15,250
-4% -$697K 0.78% 71
2018
Q2
$17.8M Buy
409,000
+11,213
+3% +$523K 0.83% 71
2018
Q1
$18.3M Buy
397,787
+8,293
+2% +$402K 0.86% 69
2017
Q4
$19.7M Buy
389,494
+7,845
+2% +$413K 0.91% 68
2017
Q3
$19.8M Sell
381,649
-47,689
-11% -$2.32M 0.97% 65
2017
Q2
$21M Buy
429,338
+7,806
+2% +$362K 1.06% 51
2017
Q1
$19.8M Buy
421,532
+4,305
+1% +$205K 1.03% 57
2016
Q4
$20M Sell
417,227
-19,369
-4% -$888K 1.07% 48
2016
Q3
$17.3M Buy
436,596
+32,588
+8% +$1.23M 0.94% 65
2016
Q2
$14.3M Buy
404,008
+2,614
+0.7% +$102K 0.79% 76
2016
Q1
$15.7M Buy
401,394
+12,569
+3% +$470K 0.9% 69
2015
Q4
$16.7M Buy
388,825
+11,305
+3% +$497K 1% 60
2015
Q3
$15.9M Buy
377,520
+4,084
+1% +$191K 1% 61
2015
Q2
$18.6M Buy
373,436
+4,871
+1% +$231K 1.1% 46
2015
Q1
$16.6M Buy
368,565
+25,329
+7% +$1.14M 0.99% 66
2014
Q4
$16.5M Buy
343,236
+10,502
+3% +$499K 0.95% 67
2014
Q3
$15.9M Buy
332,734
+4,891
+1% +$238K 0.97% 62
2014
Q2
$16.2M Buy
327,843
+8,724
+3% +$408K 0.97% 66
2014
Q1
$15M Buy
319,119
+2,861
+0.9% +$131K 0.94% 67
2013
Q4
$15.2M Sell
316,258
-1,762
-0.6% -$79K 0.98% 63
2013
Q3
$13.3M Sell
318,020
-28,604
-8% -$1.23M 0.93% 66
2013
Q2
$14.1M Buy
+346,624
New +$12.7M 1% 64

Other funds holding MET

Vaughan David Investments's MET Position: Q1 2026 in Review

Vaughan David Investments sold out of MetLife (MET) in Q1 2026, closing a stake of 2,793 shares — an estimated $220K sold.

Vaughan David Investments first reported a position in MET in Q2 2013 and held it in 51 quarters. The position peaked at $21M in Q2 2017. 1,381 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Vaughan David Investments reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Vaughan David Investments sold 2,793 MetLife shares in Q1 2026, an estimated $220K.
  • Vaughan David Investments first reported a position in MetLife in Q2 2013 and held it in 51 quarters.
  • Vaughan David Investments's MetLife position peaked at $21M in Q2 2017.
  • 1,381 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Vaughan David Investments's 13F filing for Q1 2026, filed 12 May 2026.